BK
BKYI.US BIO-key International, Inc. Common Stock
- Market cap
- USD 4.31M
- P/E
- -
- P/B
- 1.20x
- ROE
- -33.2%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is BKYI.US undervalued?
Graham numberThe Graham number of BIO-key International, Inc. Common Stock cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
BIO-key International, Inc. Common Stock fundamental analysis
No fundamental analysis for BIO-key International, Inc. Common Stock yet.
BIO-key International, Inc. Common Stock stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About BIO-key International, Inc. Common Stock
BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions in the United States and internationally. It offers BIO-key PortalGuard and PortalGuard IDaaS cloud-based identity platforms, which allows authentication through an IAM platform; and BIO-key VST and WEB-key; civil and large-scale ID infrastructure. The company also provides fingerprint readers for c…
Full company profileBIO-key International, Inc. Common Stock financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
BIO-key International, Inc. Common Stock annual financial statements
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 2.98M | 6.30M | 4.04M | 2.27M | 2.84M | 5.11M | 7.02M | 7.75M | 6.93M | 6.10M | 7.40M |
| Gross Profit | 2.25M | -181K | -120K | -194K | 2.04M | 3.44M | 4.58M | 1.43M | 5.64M | 4.72M | 6.38M |
| Operating Income | -4.20M | -4.28M | -6.87M | -13.5M | -5.20M | -4.94M | -9.92M | -8.83M | -4.01M | -4.26M | -1.96M |
| EBITDA | -4.14M | -2.70M | -5.13M | -12.5M | -4.90M | -4.53M | -11.4M | -7.85M | -3.55M | -3.88M | -1.84M |
| Net Income | -4.19M | -4.28M | -6.87M | -14.6M | -9.67M | -5.07M | -11.9M | -8.52M | -4.30M | -4.59M | -2.17M |
| EPS | -1,080 | -927 | -852 | -1,477 | -224 | -117 | -273 | -152 | -21 | -6.91 | -1.62 |
| Balance Sheet | |||||||||||
| Total Assets | 17.3M | 16.1M | 11.7M | 2.50M | 22.5M | 17.8M | 11.3M | 4.52M | 8.62M | 10.9M | 8.84M |
| Total Liabilities | 1.84M | 2.33M | 1.23M | 4.78M | 2.19M | 2.15M | 6.04M | 3.45M | 4.84M | 3.20M | 2.30M |
| Shareholders' Equity | 15.5M | 13.8M | 10.5M | -2.29M | 20.3M | 15.6M | 5.30M | 1.06M | 3.77M | 7.67M | 6.54M |
| Cash & Short-term Investments | 1.06M | 289K | 324K | 592K | 17.5M | 7.75M | 2.64M | 511K | 438K | 2.69M | 2.22M |
| Total Debt | - | - | - | 2.82M | 730K | 264K | 3.24M | 365K | 1.78M | 704K | 134K |
| Cash Flow | |||||||||||
| Operating Cash Flow | -4.45M | -2.47M | -1.61M | -1.85M | -4.95M | -8.98M | -6.23M | -3.79M | -2.91M | -4.66M | -3.51M |
| Capital Expenditure | 53.0K | 227K | 82.5K | 30.5K | 35.6K | 42.0K | 82.0K | 1.00K | 13.0K | 12.0K | 16.6K |
| Free Cash Flow | -4.50M | -2.69M | -1.70M | -1.88M | -4.99M | -9.02M | -6.31M | -3.79M | -2.93M | -4.67M | -3.52M |
| Ratios | |||||||||||
| ROE | -27.1% | -31.1% | -65.6% | - | -47.6% | -32.4% | -224.6% | -801.3% | -114.0% | -59.9% | -33.2% |
| ROA | -24.2% | -26.6% | -58.7% | -584.3% | -43.0% | -28.5% | -105.0% | -188.7% | -49.9% | -42.2% | -24.5% |
| Net Profit Margin | -140.8% | -67.8% | -169.8% | -643.4% | -341.0% | -99.0% | -169.7% | -109.9% | -62.1% | -75.3% | -29.3% |
| Debt to Equity | - | - | - | - | 0.04x | 0.02x | 0.61x | 0.34x | 0.47x | 0.09x | 0.02x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
BIO-key International, Inc. Common Stock dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
| 2019 | - | - | - |
| 2018 | - | - | - |
| 2017 | USD 630K | 137 | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1:10 on Apr 30, 2026.
Who owns BIO-key International, Inc. Common Stock
- Insiders 8.66%
- Institutions 4.78%
- Public & others 86.56%
- Shares outstanding 2.04M
- Free float 1.35M
Top funds holding BKYI.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| NT Ext Eq Mkt Idx Fd DC Lending Tier 5 | 86.00 | 0.00% | +1.18% | Mar 2026 |
Top institutions holding BKYI.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| HARBOUR INVESTMENTS, INC. | 0.00 | 0.00% | -100.00% | Jun 2026 |
| Morgan Stanley - Brokerage Accounts | 0.00 | 0.00% | -100.00% | Jun 2026 |
| Geode Capital Management, LLC | 0.00 | 0.00% | -100.00% | Jun 2026 |
| Tower Research Capital LLC | 0.00 | 0.00% | -100.00% | Jun 2026 |
| Vanguard Capital Management, LLC | 0.00 | 0.00% | -100.00% | Jun 2026 |
| SBI Securities Co Ltd | 0.00 | 0.00% | -100.00% | Jun 2026 |
| Citigroup Inc | 0.00 | 0.00% | -100.00% | Jun 2026 |
| Global Retirement Partners, LLC. | 0.00 | 0.00% | -100.00% | Jun 2026 |
| UBS Group AG | 0.00 | 0.00% | -100.00% | Jun 2026 |
BIO-key International, Inc. Common Stock company profile
- Company name
- BIO-key International, Inc. Common Stock
- Ticker
- BKYI.US
- Exchange
- USA Stocks
- Listed since
- Feb 14, 1997
- Sector
- Industrials
- Industry
- Software
- Employees
- 41
- Fiscal year end
- December
- Address
- 101 Crawfords Corner Road, Holmdel, NJ, United States, 07753
- Phone
- 732 359 1100
- Website
- bio-key.com
About BIO-key International, Inc. Common Stock
BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions in the United States and internationally. It offers BIO-key PortalGuard and PortalGuard IDaaS cloud-based identity platforms, which allows authentication through an IAM platform; and BIO-key VST and WEB-key; civil and large-scale ID infrastructure. The company also provides fingerprint readers for commercial companies under the SidePass, SideSwipe, and EcoID II brands; and identity and access management, user multi-factor authentication, single sign on, privilege entitlement, and access control. It serves commercial, government, and education customers. The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc. in 2002. BIO-key International, Inc. was founded in 1993 and is headquartered in Holmdel, New Jersey.
BIO-key International, Inc. Common Stock management
8- Mr. Michael W. DePasqualeChairman & CEO · born 1955
- Mr. Kwok Fong WongMD of Hong Kong & Vice-Chairman of the Board · born 1963
- Ms. Cecilia C. WelchChief Financial Officer · born 1960
- Mr. James David SullivanSenior VP of Strategy & Compliance and Chief Legal Officer · born 1967
- Ms. Mira K. LaCousChief Technology Officer · born 1962
- Mr. Akintunde Carlton JejeManaging Director of Africa
- Mr. Alex RochaManaging Director of EMEA
- Mr. Stephen MorrowPresident of PortalGuard®